FDA approves antidepressant drug for treatment of seasonal depression.
D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D016642:Bupropion / Q000627:therapeutic use*; D006801:Humans; D016574:Seasonal Affective Disorder / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D018687:Antidepressive Agents, Second-Generation; D016642:Bupropion